Supplementary Figure S3 from Pembrolizumab with Chemotherapy for Patients with Recurrent or Metastatic Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma: A Prospective Phase ll Study
Open Access
- 17 June 2026
- other
- Published by American Association for Cancer Research (AACR)